1.It is often affected in lymphocytic leukemias and lymphomas.
它经常受到淋巴细胞性白血病和淋巴瘤的影响。
2.For the treatment of a variety of acute leukemias, also effective to chorionic epithelial cancer and malignant mole.
用于各种急性白血病的治疗，对绒毛膜上皮癌及恶性葡萄胎也有效。
3.According to the two hit hypothesis, most acute leukemias are the consequence of a collaboration of several types of mutations.
根据“二次打击”的学说，白血病的发生一般是多个基因改变的综合结果。
4.Lymphoproliferative malignancies include lymphomas and acute lymphoblastic and chronic lymphocytic leukemias.
恶性淋巴增生包括淋巴瘤、急性淋巴细胞白血病和慢性淋巴细胞白血病。
5.Chronic lymphocytic leukemia and chronic myelogenous leukemia usually progress slowly compared to acute leukemias.
相对于急性白血病，慢性淋巴细胞白血病和慢性粒细胞性白血病通常进展缓慢。
6.Besides human leukemias and lymphomas, microRNA genes also have been found in human lung, breast and colon cancers .
除了人类的白血病和淋巴癌，人类肺癌，乳腺癌和结肠癌中也发现了微RNA基因。
7.This results in the induction of a broad range of leukemias and lymphomas.
这引起广泛白血病和淋巴瘤的诱导发生。
8.This receptor is broadly distributed in carcinomas, sarcomas , leukemias, and lymphomas.
这种受体广泛分布与癌、肉瘤、白血病、淋巴瘤。
9.Viral insertion into critical genes has triggered lethal leukemias in several gene therapy recipients.
在数个接受基因疗法的患者中，发现有病毒插入重要的基因而引发致命的白血病。
10.B-cell CLL constitutes one fourth of all leukemias but less than 5% of adult leukemias in Asian populations.
B细胞CLL约占所有白血病的四分之一，但是在亚洲人身上，仅占成人白血病的不到5%；